Editas Medicine, Inc., Announces Pricing Of $50 Million Offering Of Common Stock
December 06, 2017 at 12:25 PM EST
Editas Medicine, Inc., a leading genome editing company, today announced the pricing of an underwritten offering of 1,970,000 shares of its common stock.
